- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 104.72M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 104.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 87.46M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.19M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.51M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$22.48M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$17.96M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $159.62M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $115.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $73.59M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $124.25M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $71M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $254.77M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $261.19M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $207.35M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $202.96M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $39.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $39.63M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $70.63M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $72.98M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $258.2M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $267.95M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $325.4M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $334.16M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.29 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $17.9M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $12.26M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $14.54M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $12.64M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$30.03M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$15.75M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$32.16M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$17.7M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $15.19M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $13.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $15.47M |
| Revenue | Q1 2026 · Mar 31, 2025 | $20.61M |